This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Es Cell International Pte Ltd, Other. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 24 
1 out of 834,513 Years Active: 2012-2016
Title: William Sun: Innovator in Cardiomyocyte Differentiation
Introduction
William Sun is a prominent inventor based in Singapore, known for his significant contributions to the field of stem cell research. He holds 2 patents that focus on the differentiation of cardiomyocytes from embryonic stem cells. His work has the potential to advance cardiac therapies and regenerative medicine.
Latest Patents
William Sun's latest patents include groundbreaking inventions related to the induction of differentiation in human embryonic stem (hES) cells to cardiomyocytes. The first patent details the use of factors such as prostaglandin I2 (PGI2), Fgf 9, Bmp6, Bmp4, Scf, Igf2, and insulin that influence this differentiation process. It also provides media suitable for inducing cardiomyocyte differentiation from hES cells, along with genes that are upregulated during this process. The second patent focuses on prostacyclin-directed differentiation of cardiomyocytes from human embryonic stem cells. This invention highlights the use of prostaglandin in combination with essential minerals and small molecules to enhance the differentiation process. It also discusses the application of the produced cardiomyocytes and cardiac progenitors in transplantation and screening for cardiac compounds.
Career Highlights
William Sun has worked with Es Cell International Pte Ltd, where he has made significant strides in stem cell research. His innovative approaches have positioned him as a key figure in the development of therapies aimed at treating cardiac conditions.
Collaborations
Throughout his career, William has collaborated with notable professionals in the field, including Christine Lindsay Mummery and Ralph Eberhard Graichen. These collaborations have further enriched his research and contributed to advancements in cardiomyocyte differentiation.
Conclusion
William Sun's work in the differentiation of cardiomyocytes from embryonic stem cells represents a significant advancement in regenerative medicine. His patents and collaborations highlight his commitment to improving cardiac therapies and enhancing our understanding of stem cell biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile